Mohan Srinivasan

This inventor holds 78 USPTO granted patents and 30 published patent applications, plus 10 CIPO patents and 27 EPO patents, primarily in Monoclonal Antibodies (CPC class C07K). Top assignees: Bristol-Myers Squibb Compnay, Medarex Inc., E. R. Squibb Sons, Inc.. Active years: 2006-2025.

USPTO Granted Patents = 78 (Patent Applications = 30)

% Patents Active = 92.3

CIPO Patents = 10 (Patent Applications = 15)

EPO Patents = 27 (Patent Applications = 36)

Average Co-Inventor Count = 5.8

ph-index = 21

Forward Citations = 3,551(Granted Patents)

Forward Citations (Not Self Cited) = 3,315(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Santa Clara, CA (US) (2009 - 2011)
San Jose, CA (US) (2010 - 2019)
Cupertino, CA (US) (2006 - 2024)

Company Filing History:

33 out of 3,736

Bristol-Myers Squibb Compnay

E. R. Squibb Sons, Inc.

patents

4. 8 out of 575

Ono Pharmaceutical Co., Ltd.

patents

5. 7 out of 540

Network Appliance, Inc.

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

CD25

PD-1

GITR

OX40

LAG-3

TIGIT

Cancer Diagnostics

Therapeutics

Bispecific Antibodies

Inflammation Treatment

Human Antibodies

78 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441803 - Engineered CD25 polypeptides and uses thereof (2025-10-14),

2. 12215163 - CD25 antibodies (2025-02-04),

3. 12110337 - Anti-CD27 antibodies and uses thereof (2024-10-08),

4. 12060421 - Antibodies to TIGIT (2024-08-13),

5. 11802162 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2023-10-31),

6. 11708405 - IP-10 antibodies and their uses (2023-07-25),

7. 11623965 - Prodruggable antibodies, prodrugs thereof, and methods of use and making (2023-04-11),

8. 11466092 - Antibodies against OX-40 and uses thereof (2022-10-11),

9. 11408889 - Anti-GITR antibodies for cancer diagnostics (2022-08-09),

10. 11352440 - Antibodies against CD73 and uses thereof (2022-06-07),

11. 11345752 - Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof (2022-05-31),

12. 11242393 - Antibodies against MICA and/or MICB and uses thereof (2022-02-08),

13. 11213586 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) (2022-01-04),

14. 11084881 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2021-08-10),

15. 11072664 - Interferon receptor 1 antibodies and their uses (2021-07-27),

Title: Mohan Srinivasan: Pioneering Inventor from Cupertino

Introduction: Mohan Srinivasan is a distinguished inventor based in Cupertino, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Mohan Srinivasan holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Mohan Srinivasan has worked with top tech companies, leading research institutions, and universities, where he has spearheaded projects that have revolutionized the industry.

Collaborations: Mohan Srinivasan has collaborated with renowned inventors, patent attorneys, and research teams worldwide, fostering a culture of innovation and knowledge sharing that has led to significant advancements in various technological domains.

Conclusion: Mohan Srinivasan's passion for innovation, coupled with his relentless drive to solve complex problems, has solidified his reputation as a visionary inventor at the forefront of technological progress.